2 followers
Zymeworks (NYSE:ZYME) is a clinical-stage biopharmaceutical company dedicated to the development of next-generation multifunctional biotherapeutics.
Industries
Headquarters
Stage
Employees
Links
View full screen
Kenneth Galbraith
View all
7 members
5 members
4 members
Coherus BioSciences
5 followers
BioMarin Pharmaceutical
20 followers
Adaptive Biotechnologies
11 followers
Eikon Therapeutics
1 follower
Triumvira Immunologics
Explore more companies